Iqvia Holdings Inc. (IQV): Operating Cash Flow
$2.65B
Year ended 2025-12-31
$2.70B
Trailing 12 months to 2026-03-31
+5.5%
3-year compound annual growth
+6.3%
5-year compound annual growth
+18.7%
10-year compound annual growth
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.65B | -2.3% | 2026-02-17, From 2025-01-01 |
| 2024-12-31 | $2.72B | +26.4% | 2026-02-17, From 2024-01-01 |
| 2023-12-31 | $2.15B | -4.9% | 2026-02-17, From 2023-01-01 |
| 2022-12-31 | $2.26B | -23.2% | 2025-02-13, From 2022-01-01 |
| 2021-12-31 | $2.94B | +50.2% | 2024-02-15, From 2021-01-01 |
| 2020-12-31 | $1.96B | +38.2% | 2023-02-15, From 2020-01-01 |
| 2019-12-31 | $1.42B | +13.0% | 2022-02-16, From 2019-01-01 |
| 2018-12-31 | $1.25B | +29.3% | 2021-02-12, From 2018-01-01 |
| 2017-12-31 | $970.00M | +12.8% | 2020-02-18, From 2017-01-01 |
| 2016-12-31 | $860.00M | +80.7% | 2019-02-19, From 2016-01-01 |
| 2015-12-31 | $476.00M | +9.9% | 2018-02-16, From 2015-01-01 |
| 2014-12-31 | $433.00M | +10.1% | 2017-02-16, From 2014-01-01 |
| 2013-12-31 | $393.37M | +17.2% | 2016-02-11, From 2013-01-01 |
| 2012-12-31 | $335.70M | +108.6% | 2015-02-12, From 2012-01-01 |
| 2011-12-31 | $160.95M | n/a | 2014-02-13, From 2011-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Iqvia Holdings Inc. (IQV) | 2025-12-31 | $2.65B | -2.3% |
| Icon PLC (ICLR) | 2025-12-31 | $1.04B | -19.5% |
| Incyte Corp (INCY) | 2025-12-31 | $1.41B | +321.5% |
| Charles River Laboratories International, Inc. (CRL) | 2025-12-27 | $737.65M | +0.4% |
| Medpace Holdings, Inc. (MEDP) | 2025-12-31 | $713.22M | +17.1% |
| NRC Health (NRC) | 2025-12-31 | $26.45M | -23.6% |
| MaxCyte, Inc. (MXCT) | 2025-12-31 | -$34.41M | n/m |
| OmniAb, Inc. (OABI) | 2025-12-31 | -$36.45M | n/m |
| Foxo Technologies Inc. (FOXO) | 2025-12-31 | -$3.87M | n/m |
Compare IQV, ICLR, INCY, CRL side by side · Screen every company in Services-Commercial Physical & Biological Research ↗